Table 3.

Prevalence of combined virulence determinants among E. faecalis isolates in urine and feces specimens of patients with community acquired-UTIs

Genotype patterns	Urine samples N = 63 (%)	Fecal samples N = 63 (%)
esp+, efbA+, asa+, ace+, cyl+, gelE+	25 (39.6%)	23 (36.5%)
esp+, efbA+, asa+, ace+, cyl+	6 (9.5%)	1 (1.5%)
esp+, efbA+, asa+, ace+, gelE+	9 (14.2%)	7 (11.1%)
esp+, efbA+, ace+, cyl+, gelE+	1 (1.5%)	3 (4.7%)
efbA+, asa+, ace+, cyl+, gelE+	2 (3.1%)	0 (0%)
esp+, efbA+, asa+, cyl+, gelE+	0 (0%)	1 (1.5%)
efbA+, asa+, ace+, gelE+	8 (12.6%)	9 (14.2%)
esp+, efbA+, ace+, gelE+	7 (11.1%)	10 (15.8%)
efbA+, ace+, cyl+, gelE+	1 (1.5%)	1 (1.5%)
efbA+, ace+, gelE+	4 (6.3%)	4 (6.3%)
esp+, efbA+, gelE+	1 (1.5%)	1 (1.5%)
esp+, efbA+, ace+	0 (0%)	1 (1.5%)
ace+, gelE+	0 (0%)	1 (1.5%)

 + , gene present

esp, Enterococcal surface protein; asa1, Aggregation substance; ace, Adhesion of collagen of enterococci; cyl, Cytolysin; gelE, Gelatinase; efbA, Pav A-like fibronectin-binding protein